Exagen | 3.06 +0.05 +1.66% | ||
| XGN | |||
| 高 3.08 | 开 2.93 | 量 10.56万股 | 总市值 7360.24万 |
| 低 2.91 | 换 0.44% | 额 32.06万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Exagen(XGN)
03-17 09:25
$Exagen(XGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001274737-26-000011 Size: 3 KB 网页链接
Exagen(XGN)
03-17 07:25
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-26-000006 Size: 8 KB 网页链接
Exagen(XGN)
03-17 07:25
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001449439-26-000005 Size: 9 KB 网页链接
Exagen(XGN)
03-10 21:25
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-26-000009 Act: 34 Size: 12 MB 网页链接
Exagen(XGN)
03-10 20:05
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-26-000007 Act: 34 Size: 371 KB 网页链接
Exagen(XGN)
03-05 04:05
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-26-000004 Size: 7 KB 网页链接
Exagen(XGN)
02-26 08:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001449439-26-000003 Size: 4 KB 网页链接
Exagen(XGN)
02-26 08:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-26-000002 Size: 5 KB 网页链接
Exagen(XGN)
02-17 21:35
$Exagen(XGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493215-26-000034 Act: 34 Size: 13 KB 网页链接
Exagen(XGN)
02-12 05:25
$Exagen(XGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001140361-26-004799 Act: 34 Size: 10 KB 网页链接
Exagen(XGN)
02-05 03:35
$Exagen(XGN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002042077-26-000013 Act: 34 Size: 6 KB 网页链接
Exagen(XGN)
01-12 22:05
$Exagen(XGN)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001274737-26-000003 Act: 34 Size: 175 KB 网页链接
Exagen(XGN)
2025-11-04 22:25
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-25-000071 Act: 34 Size: 6 MB 网页链接
Exagen(XGN)
2025-11-04 21:05
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-25-000069 Act: 34 Size: 320 KB 网页链接
Exagen(XGN)
2025-10-21 05:35
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-25-000003 Size: 5 KB 网页链接
Exagen(XGN)
2025-09-05 07:45
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041688 Size: 5 KB 网页链接
Exagen(XGN)
2025-08-15 01:55
$Exagen(XGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000935836-25-000525 Act: 34 Size: 6 KB 网页链接
Exagen(XGN)
2025-08-14 20:15
$Exagen(XGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001415889-25-021708 Act: 34 Size: 9 KB 网页链接
Exagen(XGN)
2025-07-29 21:25
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-25-000063 Act: 34 Size: 6 MB 网页链接
Exagen(XGN)
2025-07-29 20:05
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-25-000061 Act: 34 Size: 319 KB 网页链接